Latest Articles
PRM Welcomes Dr. Faraj Touchan, MD, to Enhance Endometriosis Care in the Tri-State - The Manila Times
PRM Welcomes Dr. Faraj Touchan, MD, to Enhance Endometriosis Care in the Tri-State The Manila Times
Published: June 3, 2025, 2:09 p.m.
Does Endometriosis Complicate Pregnancy? - Medscape
Does Endometriosis Complicate Pregnancy? Medscape
Published: June 3, 2025, 11:16 a.m.
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com Canada
Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com Canada
Published: June 3, 2025, 8:43 a.m.
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com
Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com
Published: June 3, 2025, 8:41 a.m.
Aussie tradie and endometriosis campaigner Brett Hinton reveals why we need to 'smash the stigma' - Nine - Honey
Aussie tradie and endometriosis campaigner Brett Hinton reveals why we need to 'smash the stigma' Nine - Honey
Published: June 3, 2025, 6:47 a.m.
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer - Insider Monkey
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer Insider Monkey
Published: June 3, 2025, 5 a.m.
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic - MedCity News
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic MedCity News
Published: June 3, 2025, 1:19 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab (GMAB) Announces Promising Rina-S Data from Endometrial C - GuruFocus
Genmab (GMAB) Announces Promising Rina-S Data from Endometrial C GuruFocus
Published: June 2, 2025, 7:20 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Link copied to clipboard!